Establishment Labs Holdings Inc. announced that the Motiva Flora SmoothSilk Tissue Expander was used for the first time in the United States at the University of Texas MD Anderson Cancer Center in Houston by Mark Clemens, MD MBA FACS, Professor of Plastic Surgery. The recent FDA clearance and first procedure mark significant developments in the field of plastic and reconstructive surgery. The Flora Tissue Expander includes several proprietary innovations, including Establishment Labs' patented SmoothSilk surface technology and an RFID-enabled, non-magnetic port, labeled as MR Conditional by the FDA.

SmoothSilk has been shown to produce the least amount of inflammation and foreign body response compared to other device surfaces. By being magnet-free, Flora avoids the interference that magnets cause during MRI and may improve the precision of radiation oncology treatment. All other commercially available breast tissue expansion include magnets.